Intracranial Stenosis Stents Market Size

Intracranial Stenosis Stents Market Size

Intracranial Stenosis Stents Market size was valued at USD 790 million in 2022 and is estimated to account for USD 1.3 billion by 2032.

Intracranial stenosis stents are medical devices used to treat the narrowing of blood vessels within the brain, a condition known as intracranial stenosis. These stents are small, flexible metal mesh tubes implanted in the narrowed blood vessels to widen and reinforce them, restoring proper blood flow and reducing the risk of stroke. Intracranial stenting or angioplasty with stenting is minimally invasive and involves delivering the stent through a catheter inserted into an artery, usually accessed through the femoral artery in the leg.
 

This approach aims to prevent ischemic strokes and improve patient outcomes by promoting better blood flow to the affected brain region. The market for intracranial stenosis stents is anticipated to grow owing to the growing awareness of minimally invasive treatment options and the advancement of medical technologies.
 

The growing prevalence of intracranial diseases, such as stroke and atherosclerosis is one of the major driving factors for the market progress. There has been a significant increase in the incidence of intracranial diseases such as atherosclerosis and vascular conditions worldwide. These conditions partially lead to intracranial stenosis, where blood vessels in the brain narrow, potentially causing strokes and other neurological complications. Additionally, several factors such as an aging population base and lifestyle changes contribute to the rising prevalence of risk factors including hypertension and diabetes, that lead to intracranial disease.
 

For instance, according to the American Heart Association (AHA), each year about 795,000 new or recurrent strokes occur in the U.S. The prevalence has resulted in a higher demand for effective treatment, such as intracranial stenosis stents, to manage the condition and reduce the risk of stroke-related complications. Furthermore, patients and healthcare providers are increasingly seeking minimally invasive treatment options due to their numerous benefits. Compared to traditional surgical procedures, minimally invasive approaches involve smaller incisions, reduced trauma, shorter hospital stays, and quicker recovery times. Intracranial stenting is a less invasive alternative to open surgeries making it more appealing to patients and contributing to market expansion.